We often think of mental health as residing solely in the brain, but the truth is far more intricate
MedBound Hub GLP-1 Drugs: Fighting Diabetes and Weight Gain General Madhumathi.N.Lambi December 25, 2025, 1:49pm 1 GLP-1 Drugs: Fighting Diabetes and Weight In recent years, GLP-1 receptor agonists have transformed the treatment landscape for type 2 diabetes and obesity, blurring the line between metabolic disease management and weight-loss therapy
Why Semaglutide and Tirzepatide are Different than Traditional Generics GLP-1s introduce a distinct risk profile compared to conventional small-molecule generics: High Patient Exposure: These products are prescribed at a large scale, often across diverse populations, increasing the statistical likelihood of safety signals and amplifying regulatory scrutiny
Nephrologists should embrace the holistic CKM approach to chronic disease and be part of the ongoing metabolic revolution by thinking beyond T2DM and becoming familiar with the beneficial effects of GLP-1 RAs on CVD and CKD risk in patients with overweight/obesity independent of the presence of T2DM or CKD
Honestly, its exhausting
Stopping treatment with weight loss medications is associated with gradual weight gain and a loss of earlier improvements in heart and metabolic health, according to new research published by The BMJ
